KCT0004466已完成未知
To evaluate and compare the efficacy of 18F-FDG PET taken in hyperglycemic state, 18F-FDG PET taken in NPO state, and C-11 acetate PET in detecting and grading brain tumor
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 73
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1. Adult men and women over the age of 20
- •2. First diagnosed primary brain tumor patient
- •3. Patients scheduled to undergo cancer resection as their primary treatment
排除标准
- •1. Patients who have undergone chemotherapy or radiation therapy for pretreatment
- •2. A pregnant patient
- •3. Patients or guardians who do not understand or do not accept consent
- •4. Uncontrolled diabetes
研究者
相似试验
进行中（未招募）
不适用
PILOT STUDY ASSESSING THE EFFECTIVENESS OF 18FDG PET-CT IN THE EARLY DIAGNOSIS OF BREAST CANCER AND / OR OVARIAN CANCER IN WOMEN BRCA1 or BRCA 2 MUTATION CARRIERSBreast cancer screening in women BRCA1 or BRCA2 mutation.EUCTR2010-023935-41-ESConsorcio de Apoyo a la Investigación Biomédica en Red (CAIBER)234
已完成
不适用
Assessing the efficacy of FDG-PET(18F-fluorodeoxy glucose positron emission tomography) in the early detection of RCC (Renal cell carcinoma) in patients with ESRD(End stage renal disease)Renal cell carcinoma related with end stage renal diseaseJPRN-UMIN000009336Gunma University Hospital department of nuclear medecine150
已完成
不适用
Comparison diagnostic performance of 18F-Flurodeoxyglucose and 18F-Floroestradiol Positron Emission Tomography/Computed Tomography for Initial Staging in Estrogen Receptor Positive Breast Cancer Patients.Initial staging in ER-positive breast cancer18F-FDG, 18F-FES, 18F-Fluorodeoxyglucose, 18F-Fluroestradiol, ER-positive breast cancerTCTR20230603002ational Cyclotron and PET Centre, Chulabhorn Hospital206
招募中
Unknown
A comparative study of F-18 FBPA-PET and F-18 FDG-PET in head and neck cancerHead and neck cancerJPRN-UMIN000049242Osaka University Graduate School of Medicine85
招募中
不适用
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant gliomaJPRN-UMIN000035976Southern TOHOKU BNCT Research Center20